- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06469749
Theory-based Social Media Intervention for Non-medical Use of Prescription Opioids in Young Adults
Brief Summary
The purposes of this study are to develop and implement a peer-led intervention program on Instagram for promoting prescription opioid use management and fostering psychosocial skills among young adults who engage in non-medical use of prescription opioids in the United State. The specific aims of the study include:
(1) To implement and test the feasibility of the 12-week peer-led intervention modules on Instagram among young adults who are randomly assigned to either receive the intervention (intervention group) or not receive the intervention (control group)
Participants who are assigned to the intervention group will be paired with a peer leader and attend to peer-guided interactive modules on Instagram over 12 weeks. They will complete an online survey at 1st week and 12th week, as well as brief evening surveys every two days during the intervention. The control group will not take part in intervention activities but will complete an online survey at 1st week and 12th week.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cheuk Chi Tam, Ph.D.
- Phone Number: 803-777-6883
- Email: ctam@mailbox.sc.edu
Study Contact Backup
- Name: Xiaoming Li
- Phone Number: 803-777-8874
Study Locations
-
-
South Carolina
-
Columbia, South Carolina, United States, 29208
- University of South Carolina
-
Contact:
- Cheuk Chi Tam, Ph.D.
- Phone Number: 803-777-6883
- Email: ctam@mailbox.sc.edu
-
Principal Investigator:
- Cheuk Chi Tam, Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged 18-25 years
- from the U.S.
- can read and speak English
- engage in non-medical use of prescription opioids in the past three months: taking prescription opioids without a doctor's prescription/taking more doses of prescription opioids than what a prescription allows/using prescription opioid for reasons other than a medical purpose
- use Instagram three times a week or more in the past three months
Exclusion Criteria:
- receiving substance use interventions in the past three months
- are diagnosed with substance use disorders
- are not proficient in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 12-week peer-led intervention group on Instagram
Participants in the intervention group will receive 12-week peer-led intervention interactive modules on Instagram.
|
A pilot randomized controlled trial of the 12-weeks social media intervention for non-medical use of prescription opioids (NMUPO) among young adults will be developed upon the formative research (Aim 1) grounded in the information-motivation-behavioral-skills (IMB) model. Intervention will be delivered by peer leaders, who are well-trained recovery coaches, via private groups on Instagram. Intervention contents will be tailored to psychosocial factors contributing to NMUPO. Intervention components. Incorporating Instagram functions, the intervention is planned to include four intervention modules: (1) NMUPO knowledge module, (2) self-care module, (3) virtual goal setting/monitoring module, (4) peer support module. Intervention will be delivered by peer leaders (assisted by clinical psychology trainees a) via private groups operated by their Instagram accounts. The process will be overseen by certificated experts in clinical psychology and addiction treatment.
Other Names:
|
|
No Intervention: Control group
Participants in the control group will not engage in any intervention activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement
Time Frame: Once in every two days for 12 weeks
|
Paradata (e.g., frequencies of shares, comments, likes, and posts) on particular intervention contents)
|
Once in every two days for 12 weeks
|
|
Acceptability
Time Frame: Once in every two days for 12 weeks
|
Likert items that rate how helpful the particular intervention module is (1 = not at all to 5 = extremely).
This will be measured in the ecological momentary assessment surveys.
|
Once in every two days for 12 weeks
|
|
Feasibility of the intervention
Time Frame: Immediately at 12-week post-intervention
|
Feasibility will be assessed via the post-intervention interviews in terms of the reactions to the contents, format, concepts, and visual presentation of modules.
|
Immediately at 12-week post-intervention
|
|
Dose
Time Frame: Once in every two days for 12 weeks
|
Guided by dose operationalization for mHealth intervention, dose of intervention will be collected in three domains: (1)intervention actions (if viewing a post); (2) participant actions (if practicing a skill/completing an assignment); (3) behavioral target actions (if adopting skills outside of the intervention).
This will be measured in the ecological momentary assessment surveys.
|
Once in every two days for 12 weeks
|
|
Non-medical use of prescription opioids
Time Frame: Immediately at pre-intervention and 12-week post-intervention
|
Any behaviors to indicate (1) taking a prescription opioid without a prescription; (2) taking prescription opioids more doses than what a prescription allows; (3) using prescription opioids for reasons other than a medical purpose.
The frequency of such behaviors in the past 30 days will be assessed using the Tobacco, Alcohol, Prescription medication, and other Substance use Tool (TAPS) tool.
|
Immediately at pre-intervention and 12-week post-intervention
|
|
Usability
Time Frame: Once in every two days for 12 weeks
|
Usability will be measured using the Usefulness, Satisfaction, and Ease of use-Lite (USE-Lite) questionnaire which assesses perceived usefulness and satisfaction for specific intervention modules.
This will be measured in the ecological momentary assessment surveys.
The scale comprises a total of 15 items, with 8 items for usefulness and 7 for satisfaction.
Items are rated on a 7-point scale (1=strong disagree to 7=strong agree).
The sum score for each component will be generated, with a higher score indicating a greater level of usefulness (ranging from 8 to 56) or satisfaction (ranging from 7 to 49).
|
Once in every two days for 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Outcome expectancies
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Beliefs on positive or negative consequences of engaging in non-medical use of prescription opioids.
This will be assessed using a scale adapted from the Behaviors, Expectancies, Attitudes and College Health Questionnaire (BEACH-Q).
A total of 50 Items will be scored on a five-point Likert-type scale ranging from 0 (Not at all) to 4 (Very often or always) with higher sum scores standing for the greater level of expectancies.
The sum scores range from 0 to 200.
The scale consists of eight dimensions related to specific expectancies of opioids, including pain reduction, tension reduction, academic preference, emotion enhancement, social enhancement, guilt and dependence, cognitive impairment, and physical discomfort.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Risk perception
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Perceived vulnerability and severity of engaging in non-medical use of prescription opioids.
This will be assessed using the Perceived Risk Scale for Prescription Drug Abuse.
This scale includes 5 items on a four-option scale (1="strongly disagree" to 4 = "strongly agree".
The sum score will be generated (range = 5 to 20), with higher score indicating a greater level of perception risk for non-medical use of prescription opioids.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Action self-efficacy and coping self-efficacy
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Perceived control on making actions to stop/reduce NMUPO or confidence on coping with barriers against the actions.
This will be assessed using an adapted version of Self-Efficacy Scale.
A total of six Items will be rated on a 5-point Likert scale (1 = strong disagree, 5 = strongly agree) and can be organized into 2 subscales (coping self-efficacy and action self-efficacy) with 3 items each.
The maximum obtainable score for each subscale will be 15 points, and the minimum obtainable score is 3 points.
The sum scores will be generated for each subscale, with higher scores indicating greater levels of self-efficacy.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Depression
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Experiences of depressive symptoms in the past two weeks.
This will be assessed using the Patient Health Questionnaire-9 (PHQ-9).
Nine items will be rated on a 4-option scale (0 = not at all, 3 = nearly every day) with a minimum possible score of 0 and a maximum score of 27.
The sum score will be generated, with a higher score indicating a higher level of depression.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Anxiety
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Anxious symptom experiences in the past two weeks.
This will be assessed using the General Anxiety Disorder-7 (GAD 7).
Seven items will be rated on a 4-option scale (0 = not at all, 3 = nearly every day) with a minimum possible score of 0 and a maximum score of 21.
The sum score will be generated, with a higher score indicating a higher level of anxiety.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Resilience
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Personal capacities in response to stress such as tenacity, tolerance of negative affect, positive acceptance of change, and positive view of adversities.
This will be assessed using the Connor-Davidson resilience scale (CD-RISD).
The scale comprises of 25 items, with each rated on a 5-point scale (0 to 4).
The sum score will be generated, with a higher score indicating a greater level of resilience.
The possible sum score ranges from 0 to 100.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Other substance use
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Engagement in the use of alcohol, illicit drugs, and cigarette in the past three months.
This will be assessed using the NIDA-Modified Alcohol, Smoking and Substance Involvement Screening (NIDA-ASSIST).
The scale includes 12 dichotomous items (0= No, 1 = Yes) asking if a participant has engaged in using or misusing any of 12 individual substances.
|
immediately at pre-intervention and 12-week post-intervention
|
|
Non-medical use of prescription opioids knowledge
Time Frame: immediately at pre-intervention and 12-week post-intervention
|
Information about non-medical use of prescription opioids and relevant topics, such as misconceptions, the role of fentanyl, naloxone, and Xyalazine.
This scale will be developed according to the measure in POP4Teens and the formative study.
This scale is proposed to include 15 statements related to opioids or non-medical use of prescription opioids.
Participant will be asked to determine if a statement is true or not (0 = False, 1 = True).
Responses will then be rated by the research team, with higher scores indicating better knowledge of non-medical use of prescription opioids.
|
immediately at pre-intervention and 12-week post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00135306
- 1K01DA058768-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Young Adults
-
University of SharjahNot yet recruitingYoung AdultsUnited Arab Emirates
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
Riphah International UniversityRecruiting
-
Essilor InternationalNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingYoung Healthy AdultsHong Kong
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruitingHealthy Young AdultsPortugal
-
European University Miguel de CervantesCompletedHealthy Young AdultsSpain
-
Poznan University of Physical EducationCompletedHealthy Young AdultsPoland
Clinical Trials on Theory-based and peer-led intervention on Instagram
-
The University of Hong KongCompletedPeriodontal Diseases | Caries, DentalHong Kong
-
Wollo UniversityJimma UniversityCompleted
-
Oregon Research InstituteCompletedEating Disorder PreventionUnited States
-
Koç UniversityCompletedDiabetes Mellitus, GestationalTurkey
-
Universiti Putra MalaysiaNot yet recruitingOccupational Diseases | Occupational InjuriesMalaysia
-
Rutgers, The State University of New JerseyMerck Sharp & Dohme LLC; Thomas Jefferson UniversityCompletedInfectious Disease | Pneumonia, Bacterial | Influenza | Zoster; HerpesUnited States
-
Eskisehir Technical UniversityThe Scientific and Technological Research Council of TurkeyCompletedSedentary Lifestyle | Sedentary Behavior | Physical Activity LevelTurkey
-
Palo Alto Medical FoundationNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Asthma
-
Manish RajbanshiCompletedInternet Addiction Prevention Among Higher Secondary School StudentsNepal
-
The University of Hong KongThe Hong Kong Jockey Club Charities Trust; Tung Wah Group of Hospitals; The Salvation... and other collaboratorsRecruiting